Ropes & Gray and Bernitsas Law advised Pharmathen on the transaction. Pharmathen announced its acquisition of CBL Patras, a leading vertically integrated and US-FDA approved peptide manufacturer...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here